SCHEMBL429717

SCHEMBL429717

COc1cc(C(=O)c2cc3ccc(Cl)cc3[nH]2)cc(OC)c1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.60
FLT3 P36888 2/20 0.60
TUBB4A P04350 2/20 0.57
TUBB P07437 2/20 0.57
TUBA3C P0DPH7 2/20 0.57
TUBA1B P68363 2/20 0.57
TUBA4A P68366 2/20 0.57
TUBB4B P68371 2/20 0.57
TUBB3 Q13509 2/20 0.57
TUBB2A Q13885 2/20 0.57
TUBB8 Q3ZCM7 2/20 0.57
TUBA3E Q6PEY2 2/20 0.57
TUBA1A Q71U36 2/20 0.57
TUBA1C Q9BQE3 2/20 0.57
TUBB6 Q9BUF5 2/20 0.57
TUBB2B Q9BVA1 2/20 0.57
TUBB1 Q9H4B7 2/20 0.57
PDGFRA P16234 1/20 0.55
ALOX15 P16050 4/20 0.52
MEN1 O00255 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL426733 0.90 MEN1 (0.65) PDGFRBFLT3TUBB4ATUBBTUBA3C
SCHEMBL426735 0.86 FLT3 (0.60) PDGFRBFLT3TUBB4ATUBBTUBA3C
SCHEMBL430120 0.86 FLT3 (0.64) PDGFRBFLT3TUBB4ATUBBTUBA3C
SCHEMBL425103 0.85 FLT3 (0.60) PDGFRBFLT3TUBB4ATUBBTUBA3C
SCHEMBL426783 0.83 PDGFRB (0.74) PDGFRBFLT3TUBB4ATUBBTUBA3C
SCHEMBL6170035 0.79 MEN1 (0.63) PDGFRBFLT3ALOX15MEN1NPC1
SCHEMBL7065750 0.78 FLT3 (0.64) PDGFRBFLT3TUBB4ATUBBTUBA3C
SCHEMBL426498 0.78 PDGFRB (0.72) PDGFRBFLT3PDGFRAMEN1KMT2A
SCHEMBL31706992 0.78 PDGFRB (0.50) PDGFRBTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL31705824 0.77 FLT3 (0.64) PDGFRBFLT3TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022121-A1 INDOLES, DERIVATIVES AND ANALOGS THEREOF AND USES THEREFOR TUBB, TUBB3, TUBB1 PDGFRB 2578/4885FLT3 3889/4885TUBB4A 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.